Lisanti Capital Growth, LLC Axonics, Inc. Transaction History

Lisanti Capital Growth, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 06, 2024	BUY	$49.38 - $63.75 $1.55 Million - $2 Million	31,400 Added 41.56%	106,950 $6.66 Million
Q3 2023 Nov 02, 2023	BUY	$48.64 - $62.51 $2.87 Million - $3.69 Million	59,090 Added 358.99%	75,550 $4.24 Million
Q2 2023 Aug 11, 2023	SELL	$47.99 - $60.21 $2.01 Million - $2.52 Million	-41,895 Reduced 71.79%	16,460 $830,000
Q1 2023 May 05, 2023	SELL	$52.6 - $67.34 $4.52 Million - $5.79 Million	-85,942 Reduced 59.56%	58,355 $3.18 Million
Q4 2022 Feb 03, 2023	BUY	$59.56 - $76.6 $2.21 Million - $2.84 Million	37,025 Added 34.52%	144,297 $9.02 Million
Q3 2022 Nov 01, 2022	SELL	$57.96 - $78.12 $160,549 - $216,392	-2,770 Reduced 2.52%	107,272 $7.56 Million
Q2 2022 Aug 03, 2022	SELL	$39.5 - $64.42 $804,141 - $1.31 Million	-20,358 Reduced 15.61%	110,042 $6.24 Million
Q1 2022 May 12, 2022	BUY	$43.74 - $62.76 $5.7 Million - $8.18 Million	130,400 New	130,400 $8.16 Million
Q4 2021 Feb 04, 2022	SELL	$50.01 - $73.35 $3.33 Million - $4.88 Million	-66,499 Closed	0 $0
Q3 2021 Nov 03, 2021	SELL	$59.21 - $78.66 $3.95 Million - $5.25 Million	-66,731 Reduced 50.09%	66,499 $4.33 Million
Q2 2021 Aug 16, 2021	SELL	$51.39 - $66.9 $97,384 - $126,775	-1,895 Reduced 1.4%	133,230 $8.45 Million
Q1 2021 May 12, 2021	BUY	$49.14 - $59.89 $6.64 Million - $8.09 Million	135,125 New	135,125 $8.09 Million

234

42.1M

83.4K

65.3K

Ticker AXNX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 49,123,600
Market Cap $3.49B
Description
Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...

Get notified when there are updates to the investment portfolio of Lisanti Capital Growth, LLC, based on Form 13F filings with the SEC.

Stay updated on Lisanti Capital Growth, LLC with notifications on news.